Literature DB >> 15676109

Genetics and molecular pathogenesis of the myotonic dystrophies.

John W Day1, Laura P W Ranum.   

Abstract

Pathogenic repeat expansions were initially identified as causing either a loss of gene product, such as in fragile X mental retardation, or an expansion of a polyglutamine region of a protein, as was first shown in spinobulbar muscular atrophy (Kennedy's disease). The pathogenic effect of the repeat expansion in myotonic dystrophy type 1, however, has been controversial because it does not encode a protein but nonetheless results in a highly penetrant dominant disease. Clinical and molecular characterization of myotonic dystrophy types 1 and 2 have now demonstrated a novel disease mechanism involving pathogenic effects of repeat expansions that are expressed in RNA but are not translated into protein.

Entities:  

Mesh:

Year:  2005        PMID: 15676109     DOI: 10.1007/s11910-005-0024-1

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   5.081


  55 in total

1.  CTCF-binding sites flank CTG/CAG repeats and form a methylation-sensitive insulator at the DM1 locus.

Authors:  G N Filippova; C P Thienes; B H Penn; D H Cho; Y J Hu; J M Moore; T R Klesert; V V Lobanenkov; S J Tapscott
Journal:  Nat Genet       Date:  2001-08       Impact factor: 38.330

2.  Visualization of double-stranded RNAs from the myotonic dystrophy protein kinase gene and interactions with CUG-binding protein.

Authors:  S Michalowski; J W Miller; C R Urbinati; M Paliouras; M S Swanson; J Griffith
Journal:  Nucleic Acids Res       Date:  1999-09-01       Impact factor: 16.971

3.  Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy.

Authors:  R S Savkur; A V Philips; T A Cooper
Journal:  Nat Genet       Date:  2001-09       Impact factor: 38.330

4.  Myotonic dystrophy in transgenic mice expressing an expanded CUG repeat.

Authors:  A Mankodi; E Logigian; L Callahan; C McClain; R White; D Henderson; M Krym; C A Thornton
Journal:  Science       Date:  2000-09-08       Impact factor: 47.728

5.  Recruitment of human muscleblind proteins to (CUG)(n) expansions associated with myotonic dystrophy.

Authors:  J W Miller; C R Urbinati; P Teng-Umnuay; M G Stenberg; B J Byrne; C A Thornton; M S Swanson
Journal:  EMBO J       Date:  2000-09-01       Impact factor: 11.598

6.  Three proteins, MBNL, MBLL and MBXL, co-localize in vivo with nuclear foci of expanded-repeat transcripts in DM1 and DM2 cells.

Authors:  Majid Fardaei; Mark T Rogers; Helena M Thorpe; Kenneth Larkin; Marion G Hamshere; Peter S Harper; J David Brook
Journal:  Hum Mol Genet       Date:  2002-04-01       Impact factor: 6.150

7.  Cis and trans effects of the myotonic dystrophy (DM) mutation in a cell culture model.

Authors:  J D Amack; A P Paguio; M S Mahadevan
Journal:  Hum Mol Genet       Date:  1999-10       Impact factor: 6.150

8.  RNA leaching of transcription factors disrupts transcription in myotonic dystrophy.

Authors:  A Ebralidze; Y Wang; V Petkova; K Ebralidse; R P Junghans
Journal:  Science       Date:  2003-12-04       Impact factor: 47.728

9.  Myotonic dystrophy type 2: human founder haplotype and evolutionary conservation of the repeat tract.

Authors:  Christina L Liquori; Yoshio Ikeda; Marcy Weatherspoon; Kenneth Ricker; Benedikt G H Schoser; Joline C Dalton; John W Day; Laura P W Ranum
Journal:  Am J Hum Genet       Date:  2003-09-22       Impact factor: 11.025

10.  Foci of trinucleotide repeat transcripts in nuclei of myotonic dystrophy cells and tissues.

Authors:  K L Taneja; M McCurrach; M Schalling; D Housman; R H Singer
Journal:  J Cell Biol       Date:  1995-03       Impact factor: 10.539

View more
  14 in total

Review 1.  Silencing human genetic diseases with oligonucleotide-based therapies.

Authors:  Tamara Martínez; Natalia Wright; Marta López-Fraga; Ana Isabel Jiménez; Covadonga Pañeda
Journal:  Hum Genet       Date:  2013-03-14       Impact factor: 4.132

2.  Aberrant Expression of a Non-muscle RBFOX2 Isoform Triggers Cardiac Conduction Defects in Myotonic Dystrophy.

Authors:  Chaitali Misra; Sushant Bangru; Feikai Lin; Kin Lam; Sara N Koenig; Ellen R Lubbers; Jamila Hedhli; Nathaniel P Murphy; Darren J Parker; Lawrence W Dobrucki; Thomas A Cooper; Emad Tajkhorshid; Peter J Mohler; Auinash Kalsotra
Journal:  Dev Cell       Date:  2020-02-27       Impact factor: 12.270

Review 3.  Antisense oligonucleotides: rising stars in eliminating RNA toxicity in myotonic dystrophy.

Authors:  Zhihua Gao; Thomas A Cooper
Journal:  Hum Gene Ther       Date:  2013-01-30       Impact factor: 5.695

4.  Neuropathology does not Correlate with Regional Differences in the Extent of Expansion of CTG Repeats in the Brain with Myotonic Dystrophy Type 1.

Authors:  Kyoko Itoh; Maki Mitani; Kunihiko Kawamoto; Naonobu Futamura; Itaru Funakawa; Kenji Jinnai; Shinji Fushiki
Journal:  Acta Histochem Cytochem       Date:  2010-12-18       Impact factor: 1.938

5.  Cortical and Subcortical Grey and White Matter Atrophy in Myotonic Dystrophies Type 1 and 2 Is Associated with Cognitive Impairment, Depression and Daytime Sleepiness.

Authors:  Christiane Schneider-Gold; Barabara Bellenberg; Christian Prehn; Christos Krogias; Ruth Schneider; Jan Klein; Ralf Gold; Carsten Lukas
Journal:  PLoS One       Date:  2015-06-26       Impact factor: 3.240

Review 6.  Clinical aspects, molecular pathomechanisms and management of myotonic dystrophies.

Authors:  Giovanni Meola
Journal:  Acta Myol       Date:  2013-12

7.  Myotonic Dystrophy Type 2: An Update on Clinical Aspects, Genetic and Pathomolecular Mechanism.

Authors:  Giovanni Meola; Rosanna Cardani
Journal:  J Neuromuscul Dis       Date:  2015-07-22

8.  ClC1 chloride channel in myotonic dystrophy type 2 and ClC1 splicing in vitro.

Authors:  Simona-Felicia Ursu; Alexi Alekov; Ning-Hui Mao; Karin Jurkat-Rott
Journal:  Acta Myol       Date:  2012-10

Review 9.  A muscle stem cell for every muscle: variability of satellite cell biology among different muscle groups.

Authors:  Matthew E Randolph; Grace K Pavlath
Journal:  Front Aging Neurosci       Date:  2015-10-07       Impact factor: 5.750

10.  Age of onset of RNA toxicity influences phenotypic severity: evidence from an inducible mouse model of myotonic dystrophy (DM1).

Authors:  Jordan T Gladman; Mahua Mandal; Varadamurthy Srinivasan; Mani S Mahadevan
Journal:  PLoS One       Date:  2013-09-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.